0
Upcoming Allied Market Research
2023
Cell Dissociation Market

Cell Dissociation Market

by Product Type (Enzymatic Dissociation Products, Instruments), by Tissue (Connective Tissues, Epithelial Tissues, Others), by Dissociation (Tissue Dissociation, Cell Detachment) and by End User (Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research Institutes): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A12340
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cell Dissociation Market

Request Now !

Cell Dissociation Market Overview 2030:

The process of cell dissociation, also known as trypsinization, involves a proteolytic enzyme that aids in the breakdown of protein to dissociate adhered cells from the cell culture vessel. This breakdown is necessary so that the cells could be used further. Cell dissociation reagents can carry out proteolytic and collagenolytic activities to disengage the cell tissues and lines from glass and plastic surfaces of the container to increase cell viability and isolation efficiency. The selection of the cell dissociation agent depends on the tissue or cell type and on the age of the cells in the culture medium.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the biotechnology industry is expected to witness significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.

COVID-19 is expected to have a significant impact on the cell dissociation market, as the supply chain of raw materials required to manufacture the products for cell dissociation has been disrupted in many countries. In addition, the market growth of cell dissociation enzymes is declining, as the manufacturers of these products have slowed down their production due to the pandemic.

Top Impacting Factors

The growth of the cell dissociation market is primarily by the prevalence of cell-based research initiated by many pharmaceutical and biotechnology companies.

In addition, the number of these pharmaceutical and biotechnological companies is increasing all over the world. Hence, this is another factor fueling the growth of the cell dissociation market.

The biotechnology industry needs advanced enzymes that help dissociate tissues. This demand is further leading to the growth of the market.

However, ethical restrictions and concerns on the use of cell-based research in many regions of the world are limiting the growth of cell biology.

Key Market Trends

The enzymatic cell dissociation products segment is expected to witness lucrative growth during the forecast period, owing to increase in incidence of research where these types of enzymes are often used.

The emerging markets such as Brazil, India, and China are expected to offer significant growth opportunities for key players in the market. The expected growth can be attributable to rise in the number of cell-based research and development activities in these regions.

Key players in the market are investing in toxicity studies and efficacy studies related to cell dissociation enzymes. This factor is further expected to lead to the immense growth of the cell dissociation market during the forecast period.

North America and Europe lead the cell dissociation market, due to favorable research and development investments in many biotechnology studies, which often require cell dissociation products during the process.

Key Benefits of the Report

  • This study presents the analytical depiction of the cell dissociation industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Cell Dissociation Report

  • Which are the leading players active in the cell dissociation market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the cell dissociation market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is cell dissociation?
  • What are the current trends and predicted trends?

Cell Dissociation Market Report Highlights

Aspects Details
By Product Type
  • Enzymatic Dissociation Products
    • Collagenase
    • Trypsin
    • Papain
    • Elastase
    • DNase
    • Hyaluronidase
    • Others
  • Instruments
By Tissue
  • Connective Tissues
  • Epithelial Tissues
  • Others
By Dissociation
  • Tissue Dissociation
  • Cell Detachment
By End User
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic Institutes
  • Research Institutes
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players General Electric Company, PAN-Biotech, Becton, Dickinson and Company, VitaCyte, LLC, Roche Diagnostics, Miltenyi Biotec GmbH, HiMedia Laboratories, Merck KGaA, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc.
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: CELL DISSOCIATION MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Enzymatic Dissociation Products

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Collagenase

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Trypsin

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Papain

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Elastase

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. DNase

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Hyaluronidase

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Others

        • 4.2.4.1. Market Size and Forecast
    • 4.3. Instruments

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: CELL DISSOCIATION MARKET, BY TISSUE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Tissue

    • 5.2. Connective Tissues

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Epithelial Tissues

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: CELL DISSOCIATION MARKET, BY DISSOCIATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Dissociation

    • 6.2. Tissue Dissociation

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Cell Detachment

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: CELL DISSOCIATION MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Biotechnology Companies

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Pharmaceutical Companies

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Academic Institutes

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Research Institutes

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

  • CHAPTER 8: CELL DISSOCIATION MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product Type

      • 8.2.3. Market Size and Forecast, By Tissue

      • 8.2.4. Market Size and Forecast, By Dissociation

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Cell Dissociation Market

        • 8.2.7.1. Market Size and Forecast, By Product Type
        • 8.2.7.2. Market Size and Forecast, By Tissue
        • 8.2.7.3. Market Size and Forecast, By Dissociation
        • 8.2.7.4. Market Size and Forecast, By End User
      • 8.2.8. Canada Cell Dissociation Market

        • 8.2.8.1. Market Size and Forecast, By Product Type
        • 8.2.8.2. Market Size and Forecast, By Tissue
        • 8.2.8.3. Market Size and Forecast, By Dissociation
        • 8.2.8.4. Market Size and Forecast, By End User
      • 8.2.9. Mexico Cell Dissociation Market

        • 8.2.9.1. Market Size and Forecast, By Product Type
        • 8.2.9.2. Market Size and Forecast, By Tissue
        • 8.2.9.3. Market Size and Forecast, By Dissociation
        • 8.2.9.4. Market Size and Forecast, By End User
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product Type

      • 8.3.3. Market Size and Forecast, By Tissue

      • 8.3.4. Market Size and Forecast, By Dissociation

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Cell Dissociation Market

        • 8.3.7.1. Market Size and Forecast, By Product Type
        • 8.3.7.2. Market Size and Forecast, By Tissue
        • 8.3.7.3. Market Size and Forecast, By Dissociation
        • 8.3.7.4. Market Size and Forecast, By End User
      • 8.3.8. Germany Cell Dissociation Market

        • 8.3.8.1. Market Size and Forecast, By Product Type
        • 8.3.8.2. Market Size and Forecast, By Tissue
        • 8.3.8.3. Market Size and Forecast, By Dissociation
        • 8.3.8.4. Market Size and Forecast, By End User
      • 8.3.9. Italy Cell Dissociation Market

        • 8.3.9.1. Market Size and Forecast, By Product Type
        • 8.3.9.2. Market Size and Forecast, By Tissue
        • 8.3.9.3. Market Size and Forecast, By Dissociation
        • 8.3.9.4. Market Size and Forecast, By End User
      • 8.3.10. Spain Cell Dissociation Market

        • 8.3.10.1. Market Size and Forecast, By Product Type
        • 8.3.10.2. Market Size and Forecast, By Tissue
        • 8.3.10.3. Market Size and Forecast, By Dissociation
        • 8.3.10.4. Market Size and Forecast, By End User
      • 8.3.11. UK Cell Dissociation Market

        • 8.3.11.1. Market Size and Forecast, By Product Type
        • 8.3.11.2. Market Size and Forecast, By Tissue
        • 8.3.11.3. Market Size and Forecast, By Dissociation
        • 8.3.11.4. Market Size and Forecast, By End User
      • 8.3.12. Russia Cell Dissociation Market

        • 8.3.12.1. Market Size and Forecast, By Product Type
        • 8.3.12.2. Market Size and Forecast, By Tissue
        • 8.3.12.3. Market Size and Forecast, By Dissociation
        • 8.3.12.4. Market Size and Forecast, By End User
      • 8.3.13. Rest Of Europe Cell Dissociation Market

        • 8.3.13.1. Market Size and Forecast, By Product Type
        • 8.3.13.2. Market Size and Forecast, By Tissue
        • 8.3.13.3. Market Size and Forecast, By Dissociation
        • 8.3.13.4. Market Size and Forecast, By End User
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product Type

      • 8.4.3. Market Size and Forecast, By Tissue

      • 8.4.4. Market Size and Forecast, By Dissociation

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Cell Dissociation Market

        • 8.4.7.1. Market Size and Forecast, By Product Type
        • 8.4.7.2. Market Size and Forecast, By Tissue
        • 8.4.7.3. Market Size and Forecast, By Dissociation
        • 8.4.7.4. Market Size and Forecast, By End User
      • 8.4.8. Japan Cell Dissociation Market

        • 8.4.8.1. Market Size and Forecast, By Product Type
        • 8.4.8.2. Market Size and Forecast, By Tissue
        • 8.4.8.3. Market Size and Forecast, By Dissociation
        • 8.4.8.4. Market Size and Forecast, By End User
      • 8.4.9. India Cell Dissociation Market

        • 8.4.9.1. Market Size and Forecast, By Product Type
        • 8.4.9.2. Market Size and Forecast, By Tissue
        • 8.4.9.3. Market Size and Forecast, By Dissociation
        • 8.4.9.4. Market Size and Forecast, By End User
      • 8.4.10. South Korea Cell Dissociation Market

        • 8.4.10.1. Market Size and Forecast, By Product Type
        • 8.4.10.2. Market Size and Forecast, By Tissue
        • 8.4.10.3. Market Size and Forecast, By Dissociation
        • 8.4.10.4. Market Size and Forecast, By End User
      • 8.4.11. Australia Cell Dissociation Market

        • 8.4.11.1. Market Size and Forecast, By Product Type
        • 8.4.11.2. Market Size and Forecast, By Tissue
        • 8.4.11.3. Market Size and Forecast, By Dissociation
        • 8.4.11.4. Market Size and Forecast, By End User
      • 8.4.12. Thailand Cell Dissociation Market

        • 8.4.12.1. Market Size and Forecast, By Product Type
        • 8.4.12.2. Market Size and Forecast, By Tissue
        • 8.4.12.3. Market Size and Forecast, By Dissociation
        • 8.4.12.4. Market Size and Forecast, By End User
      • 8.4.13. Malaysia Cell Dissociation Market

        • 8.4.13.1. Market Size and Forecast, By Product Type
        • 8.4.13.2. Market Size and Forecast, By Tissue
        • 8.4.13.3. Market Size and Forecast, By Dissociation
        • 8.4.13.4. Market Size and Forecast, By End User
      • 8.4.14. Indonesia Cell Dissociation Market

        • 8.4.14.1. Market Size and Forecast, By Product Type
        • 8.4.14.2. Market Size and Forecast, By Tissue
        • 8.4.14.3. Market Size and Forecast, By Dissociation
        • 8.4.14.4. Market Size and Forecast, By End User
      • 8.4.15. Rest of Asia Pacific Cell Dissociation Market

        • 8.4.15.1. Market Size and Forecast, By Product Type
        • 8.4.15.2. Market Size and Forecast, By Tissue
        • 8.4.15.3. Market Size and Forecast, By Dissociation
        • 8.4.15.4. Market Size and Forecast, By End User
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product Type

      • 8.5.3. Market Size and Forecast, By Tissue

      • 8.5.4. Market Size and Forecast, By Dissociation

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Cell Dissociation Market

        • 8.5.7.1. Market Size and Forecast, By Product Type
        • 8.5.7.2. Market Size and Forecast, By Tissue
        • 8.5.7.3. Market Size and Forecast, By Dissociation
        • 8.5.7.4. Market Size and Forecast, By End User
      • 8.5.8. South Africa Cell Dissociation Market

        • 8.5.8.1. Market Size and Forecast, By Product Type
        • 8.5.8.2. Market Size and Forecast, By Tissue
        • 8.5.8.3. Market Size and Forecast, By Dissociation
        • 8.5.8.4. Market Size and Forecast, By End User
      • 8.5.9. Saudi Arabia Cell Dissociation Market

        • 8.5.9.1. Market Size and Forecast, By Product Type
        • 8.5.9.2. Market Size and Forecast, By Tissue
        • 8.5.9.3. Market Size and Forecast, By Dissociation
        • 8.5.9.4. Market Size and Forecast, By End User
      • 8.5.10. UAE Cell Dissociation Market

        • 8.5.10.1. Market Size and Forecast, By Product Type
        • 8.5.10.2. Market Size and Forecast, By Tissue
        • 8.5.10.3. Market Size and Forecast, By Dissociation
        • 8.5.10.4. Market Size and Forecast, By End User
      • 8.5.11. Argentina Cell Dissociation Market

        • 8.5.11.1. Market Size and Forecast, By Product Type
        • 8.5.11.2. Market Size and Forecast, By Tissue
        • 8.5.11.3. Market Size and Forecast, By Dissociation
        • 8.5.11.4. Market Size and Forecast, By End User
      • 8.5.12. Rest of LAMEA Cell Dissociation Market

        • 8.5.12.1. Market Size and Forecast, By Product Type
        • 8.5.12.2. Market Size and Forecast, By Tissue
        • 8.5.12.3. Market Size and Forecast, By Dissociation
        • 8.5.12.4. Market Size and Forecast, By End User
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. VitaCyte, LLC

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Thermo Fisher Scientific Inc.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. PAN-Biotech

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Merck KGaA

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. HiMedia Laboratories

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Miltenyi Biotec GmbH

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. STEMCELL Technologies Inc.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. General Electric Company

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Roche Diagnostics

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Becton, Dickinson And Company

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CELL DISSOCIATION MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL CELL DISSOCIATION MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL CELL DISSOCIATION MARKET, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL CELL DISSOCIATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL CELL DISSOCIATION MARKET, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL CELL DISSOCIATION MARKET FOR TISSUE DISSOCIATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CELL DISSOCIATION MARKET FOR CELL DETACHMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL CELL DISSOCIATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL CELL DISSOCIATION MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL CELL DISSOCIATION MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL CELL DISSOCIATION MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL CELL DISSOCIATION MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL CELL DISSOCIATION MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA CELL DISSOCIATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 22. U.S. CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. U.S. CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 24. U.S. CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 25. U.S. CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. CANADA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 27. CANADA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 28. CANADA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 29. CANADA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. MEXICO CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 31. MEXICO CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. EUROPE CELL DISSOCIATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 35. EUROPE CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 40. FRANCE CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 46. GERMANY CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. ITALY CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 48. ITALY CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 49. ITALY CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 50. ITALY CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 52. SPAIN CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 53. SPAIN CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 54. SPAIN CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. UK CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. UK CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 57. UK CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 58. UK CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. RUSSIA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. RUSSIA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 61. RUSSIA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 62. RUSSIA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 65. REST OF EUROPE CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 66. REST OF EUROPE CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC CELL DISSOCIATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 70. ASIA-PACIFIC CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. CHINA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 73. CHINA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 74. CHINA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 75. CHINA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. JAPAN CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 77. JAPAN CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 78. JAPAN CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 79. JAPAN CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. INDIA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 81. INDIA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 82. INDIA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 83. INDIA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH KOREA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH KOREA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. AUSTRALIA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 89. AUSTRALIA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 90. AUSTRALIA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 91. AUSTRALIA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. THAILAND CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 93. THAILAND CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 94. THAILAND CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 95. THAILAND CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. MALAYSIA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 97. MALAYSIA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 98. MALAYSIA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 99. MALAYSIA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. INDONESIA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 101. INDONESIA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 102. INDONESIA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 103. INDONESIA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. REST OF ASIA PACIFIC CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 105. REST OF ASIA PACIFIC CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 106. REST OF ASIA PACIFIC CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. LAMEA CELL DISSOCIATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 109. LAMEA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 110. LAMEA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 111. LAMEA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. BRAZIL CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 114. BRAZIL CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 115. BRAZIL CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 116. BRAZIL CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. SOUTH AFRICA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 118. SOUTH AFRICA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 119. SOUTH AFRICA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 120. SOUTH AFRICA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 121. SAUDI ARABIA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 122. SAUDI ARABIA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 123. SAUDI ARABIA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 124. SAUDI ARABIA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. UAE CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 126. UAE CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 127. UAE CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 128. UAE CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 129. ARGENTINA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 130. ARGENTINA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 131. ARGENTINA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 132. ARGENTINA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. REST OF LAMEA CELL DISSOCIATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 134. REST OF LAMEA CELL DISSOCIATION, BY TISSUE, 2022-2032 ($MILLION)
  • TABLE 135. REST OF LAMEA CELL DISSOCIATION, BY DISSOCIATION, 2022-2032 ($MILLION)
  • TABLE 136. REST OF LAMEA CELL DISSOCIATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 137. VITACYTE, LLC: KEY EXECUTIVES
  • TABLE 138. VITACYTE, LLC: COMPANY SNAPSHOT
  • TABLE 139. VITACYTE, LLC: OPERATING SEGMENTS
  • TABLE 140. VITACYTE, LLC: PRODUCT PORTFOLIO
  • TABLE 141. VITACYTE, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 143. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 144. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 145. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 146. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. PAN-BIOTECH: KEY EXECUTIVES
  • TABLE 148. PAN-BIOTECH: COMPANY SNAPSHOT
  • TABLE 149. PAN-BIOTECH: OPERATING SEGMENTS
  • TABLE 150. PAN-BIOTECH: PRODUCT PORTFOLIO
  • TABLE 151. PAN-BIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. MERCK KGAA: KEY EXECUTIVES
  • TABLE 153. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 154. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 155. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 156. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. HIMEDIA LABORATORIES: KEY EXECUTIVES
  • TABLE 158. HIMEDIA LABORATORIES: COMPANY SNAPSHOT
  • TABLE 159. HIMEDIA LABORATORIES: OPERATING SEGMENTS
  • TABLE 160. HIMEDIA LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 161. HIMEDIA LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. MILTENYI BIOTEC GMBH: KEY EXECUTIVES
  • TABLE 163. MILTENYI BIOTEC GMBH: COMPANY SNAPSHOT
  • TABLE 164. MILTENYI BIOTEC GMBH: OPERATING SEGMENTS
  • TABLE 165. MILTENYI BIOTEC GMBH: PRODUCT PORTFOLIO
  • TABLE 166. MILTENYI BIOTEC GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. STEMCELL TECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 168. STEMCELL TECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 169. STEMCELL TECHNOLOGIES INC.: OPERATING SEGMENTS
  • TABLE 170. STEMCELL TECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 171. STEMCELL TECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. GENERAL ELECTRIC COMPANY: KEY EXECUTIVES
  • TABLE 173. GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • TABLE 174. GENERAL ELECTRIC COMPANY: OPERATING SEGMENTS
  • TABLE 175. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
  • TABLE 176. GENERAL ELECTRIC COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. ROCHE DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 178. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 179. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 180. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 181. ROCHE DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 183. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 184. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 185. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 186. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL DISSOCIATION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CELL DISSOCIATION MARKET
  • FIGURE 3. SEGMENTATION CELL DISSOCIATION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CELL DISSOCIATION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCELL DISSOCIATION MARKET
  • FIGURE 11. CELL DISSOCIATION MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. CELL DISSOCIATION MARKET FOR ENZYMATIC DISSOCIATION PRODUCTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. CELL DISSOCIATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. CELL DISSOCIATION MARKET SEGMENTATION, BY BY TISSUE
  • FIGURE 15. CELL DISSOCIATION MARKET FOR CONNECTIVE TISSUES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. CELL DISSOCIATION MARKET FOR EPITHELIAL TISSUES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. CELL DISSOCIATION MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. CELL DISSOCIATION MARKET SEGMENTATION, BY BY DISSOCIATION
  • FIGURE 19. CELL DISSOCIATION MARKET FOR TISSUE DISSOCIATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. CELL DISSOCIATION MARKET FOR CELL DETACHMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. CELL DISSOCIATION MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. CELL DISSOCIATION MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. CELL DISSOCIATION MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. CELL DISSOCIATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. CELL DISSOCIATION MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: CELL DISSOCIATION MARKET
  • FIGURE 32. Top player positioning, 2022
  • FIGURE 33. VITACYTE, LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. VITACYTE, LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. VITACYTE, LLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. PAN-BIOTECH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. PAN-BIOTECH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. PAN-BIOTECH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. MERCK KGAA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. HIMEDIA LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. HIMEDIA LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. HIMEDIA LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. MILTENYI BIOTEC GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. MILTENYI BIOTEC GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. MILTENYI BIOTEC GMBH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. STEMCELL TECHNOLOGIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. STEMCELL TECHNOLOGIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. STEMCELL TECHNOLOGIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. GENERAL ELECTRIC COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. GENERAL ELECTRIC COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. GENERAL ELECTRIC COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. ROCHE DIAGNOSTICS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. ROCHE DIAGNOSTICS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. BECTON, DICKINSON AND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Cell Dissociation Market

Start reading.
This Report and over 68,439+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers